论文信息 - Efficacy and safety of melflufen plus daratumumab and dexamethasone in relapsed/refractory multiple myeloma: results from the randomized, open-label, phase III LIGHTHOUSE study - 字舞流文

Efficacy and safety of melflufen plus daratumumab and dexamethasone in relapsed/refractory multiple myeloma: results from the randomized, open-label, phase III LIGHTHOUSE study

P. Richardson | R. Hájek | M. Mateos | F. Schjesvold | M. Thuresson | A. Jurczyszyn | L. Pour | N. A. Bakker | J. Bila | V. Maisnar | S. Norin | S. Jarefors | Z. Grudeva-Popova | G. Usenko | M. Szarejko | I. Spicka